Ultrasonographic and radiographic evidence of attenuated joint destruction in early RA patients treated with infliximab
Main Authors: | Taylor, P, Steuer, A, Gruber, J, McClinton, C, Cosgrove, D, Blomley, M, Wagner, C, Marsters, R, Maini, R |
---|---|
Formato: | Conference item |
Publicado em: |
2003
|
Registos relacionados
-
JOINT DESTRUCTION IS ATTENUATED BY INFLIXIMAB IN EARLY RA PATIENTS WITH ULTRASONOGRAPHIC MARKERS OF POOR PROGNOSIS
Por: Taylor, P, et al.
Publicado em: (2003) -
Infliximab attenuates joint destruction in early RA patients with ultrasonographic markers of poor prognosis.
Por: Taylor, P, et al.
Publicado em: (2002) -
Ultrasonographic evidence of attenuated joint destruction within 18 weeks in early RA patients treated with infliximab.
Por: Taylor, P, et al.
Publicado em: (2003) -
Comparison of ultrasonographic assessment of synovitis and joint vascularity with radiographic evaluation in a randomized, placebo-controlled study of infliximab therapy in early rheumatoid arthritis.
Por: Taylor, P, et al.
Publicado em: (2004) -
Comparison of ultrasonographic measures of synovitis and radiographic assessment of structural damage over two years in a randomised, controlled trial of infliximab therapy in erosive early rheumatoid arthritis.
Por: Taylor, P, et al.
Publicado em: (2004)